Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas
Authors
Keywords
-
Journal
HUMAN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-09-23
DOI
10.1016/j.humpath.2023.09.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation between ARID1B gene mutation (p.A460, p.V215G) and prognosis of high‐risk refractory neuroblastoma
- (2023) Yi Zhang et al. CELL BIOLOGY INTERNATIONAL
- Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
- (2022) Wenying Peng et al. ONCOLOGIST
- Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma
- (2021) Yoshinori Handa et al. Clinical Lung Cancer
- ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer
- (2021) Guangsheng Zhu et al. Frontiers in Immunology
- HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
- (2021) Shen-Han Lee et al. Cells
- Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts
- (2020) Olga Sazonova et al. MODERN PATHOLOGY
- Ki-67 index of 55% distinguishes two groups of bronchopulmonary pure and composite large cell neuroendocrine carcinomas with distinct prognosis
- (2020) Massimo Milione et al. NEUROENDOCRINOLOGY
- Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer
- (2020) Antonio Raffone et al. PATHOLOGY RESEARCH AND PRACTICE
- Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer ( SCLC ) after surgical resection
- (2020) Yiying Guo et al. Thoracic Cancer
- Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization
- (2020) Marina K. Baine et al. Journal of Thoracic Oncology
- Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses
- (2019) Jung Han Woo et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential
- (2019) Jing Hu et al. Cancer Medicine
- Two cases of lung neuroendocrine carcinoma with carcinoid morphology
- (2019) Kenji Inafuku et al. Diagnostic Pathology
- The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma
- (2019) Minglei Zhuo et al. CLINICAL CANCER RESEARCH
- Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study
- (2019) Jia-Tao Zhang et al. LUNG CANCER
- ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
- (2018) Emi Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer
- (2018) Mong-Wei Lin et al. LUNG CANCER
- Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
- (2017) June-Koo Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations
- (2017) Natasha Rekhtman et al. MODERN PATHOLOGY
- Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma
- (2017) Beihe Wang et al. Journal of Cancer
- Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
- (2016) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations
- (2016) T.D. Clay et al. PATHOLOGY
- Genetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors
- (2016) Xiaohua Shi et al. Oncotarget
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose
- (2012) Hang Li et al. LUNG CANCER
- Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience
- (2011) Inderpal S. Sarkaria et al. ANNALS OF THORACIC SURGERY
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer
- (2008) A. Tatematsu et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now